Welireg bulk pharmacy
Ended Awarded Last action
- Contract number
- 36C26025F0040
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$239,578 | |
| Original award | $239,578 |
About this award
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of the cancer drug Welireg (belzutifan). The $239,578.32 contract was awarded on February 1, 2025, with a completion date of January 31, 2026. This award is a part of Merck's larger Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. Merck, a major pharmaceutical manufacturer, has an extensive portfolio of vaccines and drugs that it provides to various federal agencies, including the VA, Department of Defense, and Department of Health and Human Services. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36C26025F0040?
36C26025F0040 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on February 1, 2025.
How much is contract 36C26025F0040 worth?
The government has obligated $0 on 36C26025F0040.
Is contract 36C26025F0040 an order under another contract?
Yes. 36C26025F0040 is a delivery order under 36F79718D0509, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0040 competed?
The extent of competition for 36C26025F0040 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award